IDEX (NYSE:IEX) Price Target Raised to $220.00

IDEX (NYSE:IEX) had its target price raised by Stifel Nicolaus from $200.00 to $220.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the industrial products company’s stock. Stifel Nicolaus’ price objective suggests a potential upside of 12.64% from the company’s current price.

Several other brokerages have also issued reports on IEX. Citigroup lifted their price target on IDEX from $197.00 to $202.00 and gave the company a “buy” rating in a report on Monday, December 8th. Oppenheimer set a $210.00 target price on shares of IDEX in a research report on Tuesday, October 7th. Royal Bank Of Canada restated an “outperform” rating and set a $211.00 price target on shares of IDEX in a report on Thursday, January 15th. TD Cowen reiterated a “buy” rating on shares of IDEX in a report on Wednesday, December 3rd. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of IDEX in a research report on Wednesday, October 8th. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $203.29.

IDEX Stock Down 1.3%

Shares of IEX stock traded down $2.53 during trading on Friday, hitting $195.32. 15,524 shares of the company were exchanged, compared to its average volume of 590,425. The business’s 50-day simple moving average is $179.20 and its 200 day simple moving average is $171.78. IDEX has a twelve month low of $153.36 and a twelve month high of $226.04. The firm has a market capitalization of $14.62 billion, a price-to-earnings ratio of 30.98, a P/E/G ratio of 2.00 and a beta of 1.00. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.93.

IDEX (NYSE:IEX) last released its earnings results on Wednesday, October 29th. The industrial products company reported $2.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.10. IDEX had a net margin of 13.97% and a return on equity of 15.20%. The company had revenue of $878.70 million during the quarter, compared to the consensus estimate of $861.44 million. During the same quarter in the prior year, the firm earned $1.90 EPS. The company’s revenue was up 10.1% compared to the same quarter last year. IDEX has set its FY 2025 guidance at 7.860-7.91 EPS. As a group, analysts forecast that IDEX will post 8.26 EPS for the current fiscal year.

Institutional Trading of IDEX

Several institutional investors have recently modified their holdings of IEX. American National Bank & Trust bought a new position in IDEX in the second quarter worth $25,000. GoalVest Advisory LLC acquired a new position in shares of IDEX in the 4th quarter valued at $26,000. Capital A Wealth Management LLC acquired a new stake in shares of IDEX during the 2nd quarter valued at about $28,000. Loomis Sayles & Co. L P acquired a new position in IDEX in the second quarter worth about $33,000. Finally, UMB Bank n.a. lifted its stake in IDEX by 61.0% during the third quarter. UMB Bank n.a. now owns 198 shares of the industrial products company’s stock worth $32,000 after purchasing an additional 75 shares during the period. Institutional investors and hedge funds own 97.96% of the company’s stock.

About IDEX

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.